北美急性肺损伤市场预测至 2028 年 - COVID-19 影响和按治疗（机械通气、液体管理、药物治疗和辅助手术）和最终用户（医院、门诊手术中心等）进行的区域分析

市场介绍

北美急性肺损伤市场包括美国、加拿大和墨西哥。美国是急性肺损伤的最大市场，其次是加拿大和墨西哥。由于完善的基础设施、急性肺损伤和其他肺部疾病患病率的增加，预计美国各地的市场将会增长。慢性阻塞性肺病（COPD）和急性肺损伤等肺部疾病是美国第三大死亡原因。肺炎是急性肺损伤的直接原因。据美国胸科学会 (ATS) 称，肺炎是败血症和休克最常见的原因，占所有发作的 50%。肺炎是美国儿童住院的一个非常常见的原因。每年，美国有近 100 万人因肺炎前往医院治疗，5 万人因此死亡。此外，根据《2018年全国医院流动医疗调查》，美国肺炎诊断小组每年急诊就诊的人数和百分比分布为1485人。市场参与者正在采用有机和无机增长策略来开发市场。例如，2020 年 9 月，Stemedica Cell Technologies, Inc. 获得美国 FDA 的研究性新药 (IND) 批准，进行 II 期对照研究，旨在评估静脉内同种异体间充质干细胞治疗急性至重症肺病的安全性、耐受性和疗效因 COVID-19 受伤。因此，由于上述因素，预计急性肺损伤市场可能在预测年内呈指数级增长。

在 COVID-19 的情况下，北美尤其是美国受到严重影响。大量的新冠病例对国家和地区的经济造成了负面影响，该地区的整体商业活动和各行业的增长有所下降。市场参与者正在启动急性肺损伤药物开发的临床试验。例如，生物制药公司 Chimerix 于 2020 年 6 月启动了一项 II/III 期临床试验，以评估多西帕司他钠 (DSTAT) 在因 COVID-19 导致的急性肺损伤 (ALI) 患者中的安全性和有效性。 DSTAT 是肝素的糖胺聚糖衍生物，具有强大的抗炎特性。 Chimerix 完成了急性肺损伤 II/III 期试验的 II 期部分的入组。该研究的第 2 期部分将招募 24 名受试者来确认最大安全剂量，然后将所选剂量扩大到 50 名患者。根据积极结果，该研究的第 3 阶段部分将招募约 450 名受试者。此外，Altasciences 很高兴通过开展 I 期试验来支持 ReAlta Life Sciences，以评估 RLS-0071 治疗因病毒感染（例如 COVID-19、呼吸道合胞病毒（RSV）、和流感。作为正在进行的 ReAlta ALI 计划的一部分，I 期试验是一项单剂量递增、随机、双盲、安慰剂对照、适应性设计研究，旨在评估 RLS-0071 在治疗中的安全性、耐受性、PK 和 PD健康受试者，在加拿大蒙特利尔的 Altasciences 临床药理学部门进行。

市场概况和动态

北美急性肺损伤市场预计将从2021年的2.0193亿美元增长到2028年的2.8016亿美元；预计2021年至2028年复合年增长率为4.8%。急性肺损伤治疗市场的制造商正在重点采取产品创新、产品上市和批准以及研发投资等各种策略为取得进步，同时将并购和合作等无机战略作为其发展战略，以维持市场竞争环境。例如，Faron Pharmaceuticals, Ltd. 在一个财团的帮助下致力于开发 ALI 的药物治疗方法。 FP-1201-lyo治疗急性肺损伤正处于临床试验第三阶段，预计在预测期内获得上市许可。同样，2020 年 11 月，诺华与 Mesoblast 签订了独家许可，以制造、开发和商业化 remestemcel-L，以治疗与 COVID-19 相关的 ARDS。此外，最近在理解 ALI 病理生理学方面取得的进展引发了对许多潜在药物治疗的研究。因此，先进产品的推出可能会带来革命性的变化，并为北美急性肺损伤市场的增长提供机会。

关键细分市场

在治疗方面，机械通气细分市场在2020年北美急性肺损伤市场中占据最大份额。在最终用户方面，医院细分市场在北美市场份额较大2020年急性肺损伤市场。

主要来源和上市公司

一些主要的初级和二级准备这份北美急性肺损伤市场报告所参考的来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有Angion； Asklepion 制药有限公司；葛兰素史克公司； Qx 治疗公司； ReAlta 生命科学公司； Stemedica 细胞技术公司；和 Windtree Therapeutics, Inc。

购买报告的理由

了解北美急性肺损伤市场格局，并确定最有可能保证强劲回报的细分市场
通过了解北美急性肺损伤市场不断变化的竞争格局
通过识别最有前景的细分市场，有效规划北美急性肺损伤市场的并购和合作交易
通过对北美急性肺损伤市场各个细分市场的市场表现进行敏锐和全面的分析，有助于做出明智的业务决策
获取北美地区 2021-2028 年各个细分市场的市场收入预测.

北美急性肺损伤市场细分
北美急性肺损伤肺损伤市场 - 按治疗划分

机械通气
液体管理
药物治疗
辅助手术

北美急性肺损伤市场 - 最终用户

医院
门诊手术中心
其他

北美急性肺损伤市场 - 按国家/地区

美国
加拿大
墨西哥

北美急性肺损伤市场 - 公司简介

TABLE OF CONTENTS
1.           Introduction. 13
1.1         Scope of the Study. 13
1.2         The Insight Partners Research Report Guidance. 14
1.3         Market Segmentation. 15
1.3.1        North America Acute Lung Injury Market – By Therapy. 17
1.3.2        North America Acute Lung Injury Market – By End User 17
1.3.3        North America Acute Lung Injury Market– By Country. 17
2.           Key Takeaways. 18
3.           Research Methodology. 21
3.1         Coverage. 23
3.2         Secondary Research. 23
3.3         Primary Research. 24
4.           North America Acute Lung Injury Market– Market Landscape. 25
4.1         Overview.. 25
4.2         North America PEST Analysis. 25
4.3         Experts Opinion. 26
5.           North America Acute Lung Injury Market – Key Market Dynamics. 27
5.1         Market Drivers. 27
5.1.1        Rising Prevalence of Respiratory Diseases. 27
5.1.2        Growing Geriatric Population. 28
5.2         Market Restraints. 28
5.2.1        Expensive Therapies. 28
5.3         Market Opportunities. 29
5.3.1        Increasing Technological Advancements by Market Players. 29
5.4         Future Trends. 30
5.4.1        Surging Pipeline Drugs. 30
5.5         Impact Analysis. 30
6.           Acute Lung Injury Market– North America Analysis. 32
6.1         North America Acute Lung Injury Market Revenue Forecast and Analysis. 32
7.           North America Acute Lung Injury Market Analysis – By Therapy. 34
7.1         Overview.. 34
7.2         North America Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028) 34
7.3         Mechanical Ventilation. 35
7.3.1        Overview.. 35
7.3.2        Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 35
7.4         Fluid Management 37
7.4.1        Overview.. 37
7.4.2        Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 37
7.5         Pharmacotherapy. 39
7.5.1        Overview.. 39
7.5.2        Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 39
7.6         Adjunctive Procedures. 41
7.6.1        Overview.. 41
7.6.2        Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 41
8.           North America Acute Lung Injury Market Analysis – By End User 43
8.1         Overview.. 43
8.2         North America Acute Lung Injury Market Revenue Share, by End User (2021 and 2028) 43
8.3         Hospitals. 44
8.3.1        Overview.. 44
8.3.2        Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 44
8.4         Ambulatory Surgery Centers. 46
8.4.1        Overview.. 46
8.4.2        Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 46
8.5         Others. 48
8.5.1        Overview.. 48
8.5.2        Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 48
9.           North America Acute Lung Injury Market – Country Analysis. 50
9.1         North America: Acute Lung Injury Market 50
9.1.1        Overview.. 50
9.1.2        North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%) 52
9.1.2.1          US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 53
9.1.2.1.1          US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 54
9.1.2.1.2          US Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 55
9.1.2.1.3          US Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 55
9.1.2.2          Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 57
9.1.2.2.1          Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 57
9.1.2.2.2          Canada Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 58
9.1.2.2.3          Canada Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 59
9.1.2.3          Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 60
9.1.2.3.1          Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 60
9.1.2.3.2          Mexico Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 61
9.1.2.3.3          Mexico Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 62
10.        Impact Of COVID-19 Pandemic on North America Acute Lung Injury Market 63
10.1      North America: Impact Assessment of COVID-19 Pandemic. 63
11.        Industry Landscape. 65
11.1      Overview.. 65
11.2      Organic Developments. 65
11.2.1     Overview.. 65
11.3      Inorganic Developments. 67
11.3.1     Overview.. 67
12.        Company Profiles. 68
12.1      GlaxoSmithKline Plc. 68
12.1.1     Key Facts. 68
12.1.2     Business Description. 68
12.1.3     Products and Services. 69
12.1.4     Financial Overview.. 69
12.1.5     SWOT Analysis. 72
12.1.6     Key Developments. 73
12.2      Stemedica Cell Technologies, Inc. 74
12.2.1     Key Facts. 74
12.2.2     Business Description. 74
12.2.3     Products and Services. 75
12.2.4     Financial Overview.. 75
12.2.5     SWOT Analysis. 76
12.2.6     Key Developments. 77
12.3      Windtree Therapeutics, Inc. 78
12.3.1     Key Facts. 78
12.3.2     Business Description. 78
12.3.3     Products and Services. 79
12.3.4     Financial Overview.. 79
12.3.5     SWOT Analysis. 81
12.3.6     Key Developments. 82
12.4      ReAlta Life Sciences, Inc. 83
12.4.1     Key Facts. 83
12.4.2     Business Description. 83
12.4.3     Products and Services. 84
12.4.4     Financial Overview.. 84
12.4.5     SWOT Analysis. 85
12.4.6     Key Developments. 86
12.5      Qx Therapeutics, Inc. 87
12.5.1     Key Facts. 87
12.5.2     Business Description. 87
12.5.3     Products and Services. 88
12.5.4     Financial Overview.. 88
12.5.5     SWOT Analysis. 89
12.5.6     Key Developments. 90
12.6      Angion. 91
12.6.1     Key Facts. 91
12.6.2     Business Description. 91
12.6.3     Products and Services. 92
12.6.4     Financial Overview.. 92
12.6.5     SWOT Analysis. 94
12.6.6     Key Developments. 95
12.7      Asklepion Pharmaceuticals, LLC. 96
12.7.1     Key Facts
. 96
12.7.2     Business Description. 96
12.7.3     Products and Services. 97
12.7.4     Financial Overview.. 97
12.7.5     SWOT Analysis. 98
12.7.6     Key Developments. 99
13.        Appendix
. 100
13.1      About The Insight Partners. 100
13.2      Glossary of Terms

LIST OF TABLES
Table 1.             North America Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 33
Table 2.             US Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 55
Table 3.             US Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 55
Table 4.             Canada Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million) 58
Table 5.             Canada Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 59
Table 6.             Mexico Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million) 61
Table 7.             Mexico Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 62
Table 8.             Organic Developments Done by Companies. 66
Table 9.             Inorganic Developments Done by Companies. 67
Table 10.            Glossary of Terms

LIST OF FIGURES
Figure 1.           North America Acute Lung Injury Market Segmentation. 15
Figure 2.           North America Acute Lung Injury Market Segmentation, By Country. 16
Figure 3.           North America Acute Lung Injury Market Overview.. 18
Figure 4.           Mechanical Ventilation Segment Held the Largest Share of the Market in 2021. 19
Figure 5.           The US to Show Significant Growth During Forecast Period. 20
Figure 6.           North America PEST Analysis. 25
Figure 7.           North America Acute Lung Injury Market Impact Analysis of Driver and Restraints. 31
Figure 8.           North America Acute Lung Injury Market– Revenue Forecast and Analysis. 32
Figure 9.           North America Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028) 34
Figure 10.        North America Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 36
Figure 11.        North America Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 38
Figure 12.        North America Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 40
Figure 13.        North America Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 42
Figure 14.        North America Acute Lung Injury Market Revenue Share, by End User (2021 and 2028) 43
Figure 15.        North America Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 45
Figure 16.        North America Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 47
Figure 17.        North America Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 49
Figure 18.        North America: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million) 51
Figure 19.        North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%) 52
Figure 20.        US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 54
Figure 21.        Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 58
Figure 22.        Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 61
Figure 23.        Impact of COVID-19 Pandemic in North American Country Markets

Angion
Asklepion Pharmaceuticals, LLC.
GlaxoSmithKline Plc
Qx Therapeutics, Inc.
ReAlta Life Sciences, Inc.
Stemedica Cell Technologies, Inc
Windtree Therapeutics, Inc.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America acute lung injury market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America acute lung injury market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the acute lung injury market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022

North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022

North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.